The global dry eye syndrome drugs market to grow at a CAGR of 7.59% during the period 2017-2021.
Global Dry Eye Syndrome Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is Initiatives and programs for supporting patients with ophthalmic disorders. Public awareness about problems related to visual impairment has increased in the last decade because of the increase in the number of government initiatives undertaken by various organizations.
According to the report, one driver in the market is untapped potential in developing countries. Countries such as India, China, and Brazil are some of the most attractive countries for pharmaceutical companies globally. Several factors are responsible for the high growth of the healthcare sector in developing countries. Vast population, growing geriatric population, and lifestyle disorders such as obesity and diabetes that lead to dry eye syndrome are factors expected to drive the market in developing countries.
Further, the report states that one challenge in the market is lack of ophthalmology experts. The lack of trained ophthalmologists who have expertise in treating eye disorders such as dry eyes is one of the key challenges in the market. Although the number of people diagnosed with or prone to eyesight disorders has been on the rise, there are insufficient trained and experienced eye care professionals (ophthalmologists, optometrists, ophthalmic assistants, and ophthalmic nurses) to treat eye disorders. For instance, in Europe, there is just one ophthalmologist for every 8,000 individuals.
Other prominent vendors
Bausch & Lomb
Johnson & Johnson
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MARKET LANDSCAPE
Five forces analysis
PART 06: PIPELINE LANDSCAPE
PART 07: MARKET SEGMENTATION BY PRODUCT
OTC drugs Prescription drugs
PART 08: REGIONAL LANDSCAPE
Regional comparison Dry eye syndrome drugs market in Americas Dry eye syndrome drugs market in EMEA Dry eye syndrome drugs market in APAC Key leading countries Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers Market challenges
PART 11: MARKET TRENDS
Initiatives and programs for supporting patients with ophthalmic disorders Advancement in diagnostic techniques for dry eye syndrome
PART 12: VENDOR LANDSCAPE
PART 13: KEY VENDOR ANALYSIS
Allergan Otsuka Holdings Novartis Santen Pharmaceutical Other prominent vendors